January 30th 2020
Candice Leblanc
In October of 1999, the Institute for Molecular Biology and Medicine (IBMM) was the very first structure to settle in what was not yet the BioPark. Twenty years later, the operation is a success! Let’s take a look back at milestones in the IBMM’s history.
Until the late 1990s, ULB’s laboratories were distributed across multiple sites: the Solbosch and Erasme campuses in Brussels, and sites in Nivelles and Rhode-Saint-Genèse. In 1993, the University’s Governing Body decided to gather them all in a single place: Gosselies. This took many researchers by surprise, and a few were apprehensive…
Benefits of a presence in Wallonia
Authorities in Wallonia were looking to invest more in research and development, and researchers were very pleased with this support; still, they feared efforts would be focused on applied research projects, in order to boost job creation.
As it turns out twenty years later, these concerns were unfounded. Researchers certainly do give more thought to potential industrial applications, but funding programmes such as WELBIO have always placed significant emphasis on fundamental research. Thus, two visions that could have been in opposition to each other have instead converged.
Newcomers welcome!
The IBMM’s laboratories(1) initially benefited from their newfound proximity to one another. Later on, more organizations settled in the BioPark, creating new synergies or reinforcing existing ones.
Looking to the future
In the coming years, the IBMM is planning on reinforcing its strategic position. In terms of teaching, the Institute already hosts practical classes for the Bachelor’s in Life Sciences organized in Charleroi, as well as several training modules. There is now talk of also hosting a Master’s programme in Charleroi; if this happens, the IBMM will be at the top of the list of potential locations.
The (ongoing) recruitment of two new research professors will also provide an opportunity to restructure the IBMM’s various fields of activity into large research hubs. Stay tuned!
Notes:
Acknowledgement:
We would like to thank Bruno André, head of IBMM’s molecular physiology laboratory, for his contribution to this article.